am 251 has been researched along with Myalgia in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Myalgia: Painful sensation in the muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Muscle pain is a major clinical problem and new pharmacological approaches are being studied." | 1.40 | Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. ( Bagüés, A; Martín, MI; Sánchez-Robles, EM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagüés, A | 1 |
| Martín, MI | 1 |
| Sánchez-Robles, EM | 1 |
1 other study available for am 251 and Myalgia
| Article | Year |
|---|---|
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Topics: Analgesics; Animals; Cannabinoid Receptor Agonists; Dronabinol; Indoles; Injections, Intramuscular; | 2014 |